Data Licensing with Millennium Health for analyzing drug tests

The contract involves a data licensing agreement with Millennium Health to facilitate the analysis of drug tests. This initiative is led by the Centers for Disease Control and Prevention (CDC) and aims to leverage Millennium Health’s data capabilities to enhance drug testing analysis, supporting public health objectives. Although some specific details such as solicitation number, location, and NAICS code are not provided, the contract underscores the importance of data licensing in advancing the CDC’s efforts in monitoring and understanding drug use patterns. Key personnel include Charla Jackson, serving as the program point of contact, with the contracting officer yet to be determined. Communication regarding the contract can be directed via the provided CDC email. The contract status is currently identified as a forecast, indicating it is planned but not yet formally solicited or awarded. This forward-looking approach highlights the CDC’s strategic commitment to utilizing data-driven methods for drug testing analytics to improve health outcomes.